References
- Leung AK, Chan PY, Choi MC. Hyperhidrosis. Int J Dermatol 1999;38:561–7
- Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ 2005;172:69–75
- Strutton DR, Kowalsky JW, Glaser A, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241–24
- Kinkelin I, Hund M. Effective treatment of frontal hyperhidrosis with botulinum toxin. Br J Dermatol 2000;143:824–7
- Ramos R, Moya J. Primary hyperhidrosis and anxiety: a prospective preoperative survey of 158 patients. Arch Bronconeumol 2005;41:88–92
- Amir M, Arish A Weinstein Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis: preliminary results. Isr J Psychiatric Relat Sci 2000;37:25–31
- Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 2000;30:211–8
- White JW. Treatment of primary hyperhidrosis. Mayo Clin Proc 1986;61:951–6
- Bouman H. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phy Med 1952;31:158–69
- Connolly M, De Berker D. Management of primary hyperhidrosis. Am J Clin Dermatol 2003;4:681–97
- Lin TS, Fang HY. Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis. Surg Neurol 1999;52:453–7
- Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 1986;26: 427–53
- Franz TJ, Parsell DA, Halualani RM. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999;38: 628–32
- Housman T, Mellen B, Rapp S. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002;70:327–32
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–6
- Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweissabsonderung. Dtsch Z Nervenheilkd 1927;101: 301–6
- Naver H, Aquilonius SM. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997;4:S75–9
- Naumann M, Hamm H. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Eur J Neurol 1999;6:S111–5
- Nair B, Yamarik TA. Final report on the safety assessment of aluminium starch octenylsuccinate. Int J Toxicol 2002;21 (Suppl 1):1–7